Preclinical studies with modafinil. Evidence for vigilance enhancement and neuroprotection

Drugs of Today

Volumn 32, Issue SUPPL. I, 1996, Pages 7-21

  Fuxe, K ^a   Rambert, F A ^b   Ferraro, L ^c   O'Connor, W ^a   Laurent, Ph ^b   Agnati, L F ^a   Tanganelli, S ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Laboratoires Lafon   (France)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; MODAFINIL;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; BRAIN CORTEX; DRUG MECHANISM; ELECTROENCEPHALOGRAM; GABAERGIC SYSTEM; GUINEA PIG; MONKEY; MOUSE; NARCOLEPSY; NEUROPROTECTION; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; RAT; REVIEW;

EID: 0030447319     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. 1 -adrenergic stimulation in relation to the behaviour stimulating effect of modafinil: Studies with experimental animals. Eur J Pharmacol 1990, 180: 49-58.
2. Hermant, J.F., Rambert, F.A., Duteil, J. Awakening properties of modafinil: Effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration. Psychopharmacology 1991, 103:28-32.
3. Lin, J., Roussel, B., Akaoka, H., Fort, P., Debilly, G., Jouvet, M. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 1992, 591: 19-26.
4. De Séréville, J.E, Boer, C., Rambert, F.A., Duteil, J. Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: In vivo voltammetry studies. Neuropharmacology 1994, 33: 755-61.
5. Tanganelli, S., Ferraro, L., Bianchi, C., Beani, L. Changes in γ-aminobutyric acid release induced by topical administration of drugs affecting its metabolism and receptors: Studies in freely moving guinea pigs with epidural cups. Neurochem Int 1992, 21: 15-20.
6. Tanganelli, S., Fuxe, K., Ferraro, L., Janson, A.M., Bianchi, C. Inhibitory effects of the psychoactive drug modafinil on γ-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms. Naunyn Schmied Arch Pharmacol 1992, 345: 461-5.
7. Tanganelli, S., Pérez de la Mora, M., Ferraro, L. et al. Modafinil and cortical γ-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins. Eur J Pharmacol 1995, 273: 63-71.
8. Fuxe, K., Kurosawa, N., Cintra, A. et al. Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anaesthetized rat. Exp Brain Res 1992, 88: 131-9.
9. Ueki, A., Rosén, L., Andbjer, B. et al. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway. Exp Brain Res 1993, 93: 259-70.
10. Ueki, A., Rosén, L., Andbjer, B. et al. Evidence fora preventive action of vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat. Exp Brain Res 1993, 96: 89-99.
11. 1 adrenergic type psychostimulant on the sleep of monkeys. Psychopharmacology 1988, 96 (Suppl): Abst 31.05-09.
12. Lagarde, D., Milhaud, C. Une approche des effets psychostimulants sur l'activité electrique cérébrale chez le primate non humain, In: Electric and Magnetic Activity of the Centrai Nervous System: Research and Clinical Applications in Aerospace Medicine (Trondheim, Norway). AGARD Conference Proceedings 1988, 432: 36-1-11.
13. 1 adrenergic psychostimulant, on the sleep of rhesus monkey. Sleep 1990, 13: 441-8.
14. Lagarde, D., Anton, G. Comparative study of stimulant effects of d-amphetamine sulfate and modafinil, an original psychostimulant. Eur J Pharmacol 1990, 183: 1476.
15. Adrien, J., Lebrand, C., Maudhuit, C. Effects of modafinil on wakefulness and sleep in the rat J Sleep Res 1994, 3: 2.
16. Touret, M., Sallanon-Moulin, M., Jouvet, M. Awakening properties of modafinil without paradoxical sleep rebound. Comparative study with amphetamine in the rat. Neurosci Lett 1995, 189: 43-6.
17. Edgar, D., Seidel, W., Contreras, P., Vaught, J., Dement, W. Modafinil promotes EEG wake without intensifying motor activity in the rat. Can J Physiol Pharmacol 1994, 72 (Suppl. 1): 362.
18. Lebrand, C., Bourgin, P., Maudhuit, C., Adrien, J. Chronic treatment with modafinil in the rat: Effects on sleep-wakefulness cycles. Sleep Res 1995, 24A: 131.
19. Panckeri, A., Schotland, H., Pack, A., Hendricks, J. Modafinil decreases hypersomnolence in an animal model of sleep disordered breathing. 5th Annu Assoc Prof Sleep Soc Meet (Boston), 1994.
20. Vaught, J., Nishino, S., Shelton, J., Dement, W., Mignot, E. Differential effects of modafinil and amphetamine in canine narcolepsy: Evidence fora unique mechanism for modafinil. 5th Annu Assoc Prof Sleep Soc Meet (Boston) 1994.
21. Rambert, RA., Pessonner, J., Pointeau, A.M., Bricout, D., De Séréville, J.E., Duteil, J. Awakening properties of modafinil: Behavioural approach in the mouse. 5th Int Cong Sleep Res (June 28-July 3, Copenhagen) 1987, Abst P62.
22. Rambert, FA., Moachon, G., Multon, M.F. et al. Correlation of modafinil plasma levels to pharmacological activity in mice. Proc 5th Int Cong Sleep Res (June 28-July 3, Copenhagen) 1987, Abst P63.
23. Moachon, G., Rambert, F.A., Matinier, D., Pessonnier, J., Clenet, M., Duteil, J. Modafinil plasma levels are correlated to locomotor effect in mice. Thérapie 1990, 45: Abst 108.
24. Rambert, F.A., De Séréville, J.E., Hermant, J.F., Duteil, J. Approche comportementale des propriétés anit-hypovigilantes du modafinil chez le rat. 1 er Cong Francophone Sommeil (April 20-25, Jerba) 1992.
25. Rambert, P.A., Pessonner, J., Autran, L., Hermant, J.F., Duteil, J. Intracerebroventricularly injected modafinil (but not its main metabolites, acid and sulfone) induces hyperlocomotor activity in mice. Neuropsychopharmacology 1994, 10: 169S.
26. Rambert, F.A., Pessonner, J., Duteil, J. Modafinil-, amphetamine- and methylphenidate-induced hyperactivities in mice involve different mechanisms. Eur J Pharmacol 1990, 183: 455-6.
27. Simon, P., Hemet, C., Ramassamy, C., Costentin, J. Non amphetamine mechanism of stimulant locomotor effect of modafinil in mice. Eur Neuropsychopharmacol 1995, submitted.
28. Gold, L., Balster, R. An evaluation of the novel psychostimulant drug, modafinil, in rhesus monkey self-administration and rat drug-discrimination paradigm. In: Problems of Drug Dependence 1994. Proc 56th Annu Sci Meet Coll Prob Drug Depend, 1995. National Institute on Drug Abuse Research Monograph Series, in press.
29. Gold, L., Balster, R. An evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology 1995, submitted.
30. Hermant, J.F., Rambert, F.A., Duteil, J. Lack of cardiovascular effects after administration of modafinil in conscious monkeys. Fundam Clin Pharmacol 1991, 5: 825.
31. Duteil, J., De Séréville, J.E, Boer, C., Rambert, F.A. Lack of dopaminergic involvement in modafinil, but not amphetamine and methylphenidate, activity in anaesthetized mice and rats: In vivo voltammetry studies. Eur J Pharmacol 1990, 183: 1406-7.
32. Mignot, E., Nishino, S., Guilleminault, C., Dement, W. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 1994, 17: 436-7.
33. Akaoka, H., Roussel, B., Lin, J., Chouvet, G., Jouvet, M. Effect of modafinil on the rat catecholaminergic neuron activity. Neurosci Lett 1991, 123: 20-2.
34. Touret, M., Sallanon-Moulin, M., Fages, C. et al. Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain. Mol Brain Res 1991, 26: 123-8.
35. 1 noradrenergic control on the cortical release of acetylcholine and γ-aminobutyric acid in morphine tolerant guinea-pig. J Pharmacol Exp Ther 1988, 247: 294-301.
36. Moroni, F., Bianchi, C., Tanganelli, S., Moneti, G., Beani, L. The release of γ-aminobutyric acid, glutamate and acetylcholine from striatal slices: A massfragmentographic study. J Neurochem 1981, 36: 1691-7.
37. Bradley, P., Engel, G., Feniuk, W. et al. Proposal for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986, 25: 563-76.
38. 1H-NMR study. Brain Res 1995, 693:251-6.
39. Feeney, D., Sutton, R. Pharmacotherapy for recovery of function after brain injury. Crit Rev Neurobiol 1987, 3: 135-97.
40. Lagarde, D., Trocherie, S., Morlet, T., Mothet, J., van Beers, P. Evaluation of the effects of modafinil in hypobaric hypoxia in rhesus monkeys. Med Sci Res 1993, 21: 633-6.
41. Fuxe, K., Janson, A.M., Rosén, L. et al. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: An immunocytochemical and biochemical analysis. Exp Brain Res 1992, 88: 117-30.
42. Janson, A.M., Fuxe, K., Goldstein, M., Agnati, L.F. The MPTP model of Parkinson's disease in the mouse. Modafinil - A new potential neuroprotective agent. In: Trophic Regulation of the Basal Ganglia. Focus on Dopamine Neurons. Fuxe, K., Agnati, L., Bjelke, B., Ottoson, D. (Eds.). Pergamon Press: Oxford 1994, 409-23.
43. Sundstrom, E., Jonsson, G. Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice. Eur J Pharmacol 1986, 122: 275-8.
44. Sundstrom, E., Jonsson, G. Pharmacological interference with the neurotoxic action of 1- methyl - 4 - phenyl - 1,2,3,6 - tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse. Eur J Pharmacol 1985, 110: 293-8.
45. Ferraro, L., Tanganelli, S., O'Connor, W., Antonelli, T., Rambert, F.A., Fuxe, K. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol 1996, in press.
46. 1 ganglioside protects against the 1-methyl-4- phenyl - 1,2,3,6- tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Acta Physiol Scand 1988, 132: 587-8.
47. 1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. Neuropharmacology 1986, 9: 1075-7.
48. 1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6 - tetrahydropyridine - treated mouse. J Neurochem 1988, 51: 1190-6.
49. Agnati, L.F., Zini, I., Zoli, M. et al. Regeneration in the central nervous system: Concepts and facts. Adv Tech Standards Neurosurg 1988, 16: 3-50.
50. Agnati, L.F., Zoli, M., Biagini, G., Benfenati, F., Toffano, G., Fuxe, K. Involvement of gangliosides in neuroplasticity of the central nervous system in physiological and pathological conditions. In: Current Aspects of the Neurosciences. Osborne, N.N. (Ed). Macmillan Press Ltd.: London 1992, 33-85.
51. 1 and the trophic regulation of the basal ganglia. Focus on the nigrostriatal dopamine neurons. In: Trophic Regulation of the Basal Ganglia. Focus on Dopamine Neurons. Fuxe, K., Agnati, L., Bjelke, B., Ottoson, D. (Eds.). Pergamon Press: Oxford 1994, 1-41.
52. Agnati, L.F., Fuxe, K., Calza, L. et al. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. Acta Physiol Scand 1983, 119: 347-63.
53. Janson, A.M., Fuxe, K., Agnati, L.F. et al. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection. Brain Res 1988, 455: 332-45.
54. +) within catecholaminergic neurons. Neurotoxicology 1991, 12: 285-302.
55. Pakkenberg, B., Moller, A., Dam, A.M., Gundersen, H.J.G., Pakkenberg, H. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated unbiasedly with a stereological method. J Neurol Neurosurg Psychiatry 1991, 54: 30-3.
56. Fuxe, K., Cintra, A., Andbjer, B., Änggard, E., Goldstein, M., Agnati, L.F. Centrally administered endothelin-1 produces apnoea in the α-chloralose-anaesthetized male rat. Acta Physiol Scand 1989, 137: 157-8.
57. Fuxe, K., Kurosawa, M., Cintra, A. et al. Endothelin-1-induced lesions in the brain as a new model of focal ischemia. In: Methods in Neurosciences, Vol 7. Transplantations, Lesions, and Surgical Techniques. Conn, P. (Ed.). Academic Press: Orlando 1991, 256-82.
58. Siesjö, B. Lactic acidosis in the brain: Occurrence triggering mechanisms and pathophysiological importance. Ciba Found Symp 1982, 87: 77-100.
59. Sternau, L., Lust, W., Ricci, A., Ratcheson, R. Role for γ-aminobutyric acid in selective vulnerability in gerbils. Stroke 1989, 20: 281-7.
60. Carlsson, A., Fuxe, K., Hamberger, B., Lindquist, M. Biochemical and histochemical studies on the effects of imipramine-like and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand 1966, 67: 481-97.